Monoclonal Antibodies for COVID-19

The recent surge in COVID-19 cases has heightened interest in the use of monoclonal antibodies to treat and prevent the infection, particularly in unvaccinated patients (B. Mueller. Shunning shots but lining up for antibodies. NY Times, Sept 19, 2021, p. 1). Three monoclonal antibody products are available in the US: casirivimab and imdevimab (REGEN-COV – […]